BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30348055)

  • 1. Immunosuppression Impact on Head and Neck Cutaneous Squamous Cell Carcinoma: A Systematic Review with Meta-analysis.
    Elghouche AN; Pflum ZE; Schmalbach CE
    Otolaryngol Head Neck Surg; 2019 Mar; 160(3):439-446. PubMed ID: 30348055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
    Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
    J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
    Manyam BV; Garsa AA; Chin RI; Reddy CA; Gastman B; Thorstad W; Yom SS; Nussenbaum B; Wang SJ; Vidimos AT; Koyfman SA
    Cancer; 2017 Jun; 123(11):2054-2060. PubMed ID: 28171708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocompromised patients with metastatic cutaneous nodal squamous cell carcinoma of the head and neck: Poor outcome unrelated to the index lesion.
    Lam JKS; Sundaresan P; Gebski V; Veness MJ
    Head Neck; 2018 May; 40(5):985-992. PubMed ID: 29360262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suboptimal Outcomes in Cutaneous Squamous Cell Cancer of the Head and Neck with Nodal Metastases.
    Varra V; Woody NM; Reddy C; Joshi NP; Geiger J; Adelstein DJ; Burkey BB; Scharpf J; Prendes B; Lamarre ED; Lorenz R; Gastman B; Manyam BV; Koyfman SA
    Anticancer Res; 2018 Oct; 38(10):5825-5830. PubMed ID: 30275206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck.
    Tam S; Yao CMKL; Amit M; Gajera M; Luo X; Treistman R; Khanna A; Aashiq M; Nagarajan P; Bell D; El-Naggar A; Migden M; Wong M; Glisson B; Ferrarotto R; Esmaeli B; Rosenthal D; Li G; Weber RS; Myers JN; Gross ND
    JAMA Otolaryngol Head Neck Surg; 2020 Feb; 146(2):128-135. PubMed ID: 31804658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate of regional nodal metastases of cutaneous squamous cell carcinoma in the immunosuppressed patient.
    McLaughlin EJ; Miller L; Shin TM; Sobanko JF; Cannady SB; Miller CJ; Newman JG
    Am J Otolaryngol; 2017; 38(3):325-328. PubMed ID: 28202188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of cutaneous squamous cell carcinoma of the head and neck with parotid metastases.
    McDowell LJ; Tan TJ; Bressel M; Estall V; Kleid S; Corry J; Johnston ML
    J Med Imaging Radiat Oncol; 2016 Oct; 60(5):668-676. PubMed ID: 27324298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of nodal metastatic cutaneous squamous cell carcinoma of the head and neck treated in a regional center.
    Schmidt C; Martin JM; Khoo E; Plank A; Grigg R
    Head Neck; 2015 Dec; 37(12):1808-15. PubMed ID: 24995842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of disease-free interval in head and neck cutaneous squamous cell carcinoma with nodal metastases.
    Ebrahimi A; Clark JR; Ahmadi N; Palme CE; Morgan GJ; Veness MJ
    Head Neck; 2013 Aug; 35(8):1138-43. PubMed ID: 23152126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent primary and metastatic cutaneous head and neck squamous cell carcinoma: Analysis of prognostic factors.
    McLean T; Brunner M; Ebrahimi A; Gao K; Ch'ng S; Veness MJ; Clark JR
    Head Neck; 2013 Aug; 35(8):1144-8. PubMed ID: 22907905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
    Hirshoren N; Danne J; Dixon BJ; Magarey M; Kleid S; Webb A; Tiong A; Corry J; Gyorki D
    Head Neck; 2017 Apr; 39(4):772-778. PubMed ID: 28199044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinician perspectives on the factors influencing prognostic stratification by the American Joint Commission on Cancer Head and Neck Cutaneous Squamous Cell Carcinoma Staging.
    Watts F; Palme CE; Porceddu S; Sundaresan P; Clark JR; Gupta R
    Surgery; 2021 Nov; 170(5):1467-1473. PubMed ID: 34130810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
    J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Cutaneous Squamous Cell Carcinoma in the Head and Neck Region With Regional Lymph Node Metastasis: A Systematic Review and Meta-analysis.
    Sahovaler A; Krishnan RJ; Yeh DH; Zhou Q; Palma D; Fung K; Yoo J; Nichols A; MacNeil SD
    JAMA Otolaryngol Head Neck Surg; 2019 Apr; 145(4):352-360. PubMed ID: 30844021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous cell carcinoma antigen as a prognostic marker andĀ its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
    J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. French ENT Society (SFORL) guidelines for the management of immunodeficient patients with head and neck cancer of cutaneous origin.
    Bejar C; Basset-Seguin N; Faure F; Fieschi C; Frances C; Guenne C; Lebbe C; Peraldi MN; Roux J; Lamas G; Maubec E;
    Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Apr; 131(2):121-9. PubMed ID: 24656876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node ratio as a prognostic factor in metastatic cutaneous head and neck squamous cell carcinoma.
    Vasan K; Low TH; Gupta R; Ashford B; Asher R; Gao K; Ch'ng S; Palme CE; Clark JR
    Head Neck; 2018 May; 40(5):993-999. PubMed ID: 29360276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients.
    Tam S; Gross ND
    Curr Oncol Rep; 2019 Jul; 21(9):82. PubMed ID: 31359288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
    Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
    Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.